Market report
Pharmaceutical tenders in Czechia — market report, May 2026
Pharmaceutical tenders in Czechia in May 2026: 9,602 tenders published (+4% month on month, +13% year on year), estimated at €2,231,951,601 in total, and 9,801 contracts awarded (+4% month on month, +13% year on year), worth €141,696,474 (awarded value). Buyers with the most tenders: Fakultní nemocnice Brno (822), Fakultní nemocnice Olomouc (788) and Institut klinické a experimentální medicíny (786); most contracts won: ROCHE s.r.o. (280), Janssen-Cilag s.r.o. (220) and Takeda Pharmaceuticals Czech Republic s.r.o. (211). On average 4.5 bids per contract; 58% of contracts had a single bid. Report made on 27 October 2026.
- Tenders published
- 9,602
- Contracts awarded
- 9,801
- Contract value awarded
- €141,696,474
- Bids per contract
- 4.5
The highlighted bar is May 2026. Hover a bar for its figure; the table below has every value.
| Figure | May 2026 | April 2026 | Change | May 2025 | Change |
|---|---|---|---|---|---|
| Tenders published | 9,602 | 9,260 | +4% | 8,497 | +13% |
| Estimated value | €2,231,951,601 | €58,001,164 | +3,748% | €57,668,701 | +3,770% |
| Buyers | 92 | 88 | +5% | 83 | +11% |
| Contracts awarded | 9,801 | 9,398 | +4% | 8,665 | +13% |
| Contract value (awarded) | €141,696,474 | €727,587,209 | -81% | €56,743,815 | +150% |
| Winners | 404 | 423 | -4% | 345 | +17% |
| Bids per contract | 4.5 | 4.4 | — | 3.3 | — |
| Single-bid contracts | 58% | 52% | — | 56% | — |
Buyers with the most tenders
Companies with the most contracts
| # | Winners | Contracts |
|---|---|---|
| 1 | ROCHE s.r.o. | 280 |
| 2 | Janssen-Cilag s.r.o. | 220 |
| 3 | Takeda Pharmaceuticals Czech Republic s.r.o. | 211 |
| 4 | ViaPharma s.r.o. | 209 |
| 5 | AbbVie s.r.o. | 190 |
| 6 | Amgen s.r.o. | 143 |
| 7 | Avenier a.s. | 132 |
| 8 | Merck Sharp & Dohme s.r.o. | 121 |
| 9 | Gilead Sciences s.r.o. | 120 |
| 10 | BAYER s.r.o. | 120 |
Where the tenders were
Procedures
The report's aggregates: the figures, the comparisons and the top lists by name and count.
All reports: Medicines and pharmaceuticals
Questions and answers
- How many pharmaceutical tenders were published in Czechia in May 2026?
- 9,602 (by 92 buyers); for comparison, April 2026: 9,260, May 2025: 8,497.
- Who won the most pharmaceutical tenders in Czechia in May 2026?
- By number of contracts: ROCHE s.r.o. (280), Janssen-Cilag s.r.o. (220), Takeda Pharmaceuticals Czech Republic s.r.o. (211), ViaPharma s.r.o. (209) and AbbVie s.r.o. (190); 404 companies won contracts in all.
- Which buyers published the most pharmaceutical tenders in May 2026?
- Fakultní nemocnice Brno (822), Fakultní nemocnice Olomouc (788), Institut klinické a experimentální medicíny (786), Fakultní nemocnice Bulovka (752) and Krajská zdravotní, a.s. (712).
- How competitive were pharmaceutical tenders in Czechia in May 2026?
- On average 4.5 bids per contract (281 contracts with a known number of bids); 58% of contracts had a single bid.
- What were the contracts worth in May 2026?
- €141,696,474 (awarded value, 9,801 contracts); median about €210,000.
How the report is made
Tenders published: the tenders of the sector or topic whose first notice is dated in the month (a tender counts in its sector and in up to three topics). Contracts awarded: the awards dated in the month, whenever their tender was published. Values in EUR, by value kind (never added together); medians are approximate (±3 %). Comparisons: with the reports of the previous month and of the same month a year earlier, each made the same way. The report was made on 27 October 2026 from the data of that day and is not changed afterwards; sources publish late, so later data for the month are not in it.